id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
met-a-310	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Lactate	Inverse variance weighted	4.39556706286195	6	0.623308141634433
met-a-310	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Lactate	MR Egger	4.36397890291026	5	0.49828615936275
met-a-317	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Linoleate (18:2n6)	Inverse variance weighted	19.1690369815435	9	0.0237933624031567
met-a-317	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Linoleate (18:2n6)	MR Egger	18.9504133872909	8	0.0151270983868921
met-a-319	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Arachidonate (20:4n6)	Inverse variance weighted	13.9022724704688	11	0.238448405052099
met-a-319	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Arachidonate (20:4n6)	MR Egger	13.8975533731519	10	0.177716014706194
met-a-324	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Threonine	Inverse variance weighted	14.9884958225978	17	0.596310318615503
met-a-324	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Threonine	MR Egger	10.870930738459	16	0.817381068174474
met-a-326	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Lysine	Inverse variance weighted	14.1450510473083	13	0.36370867781003
met-a-326	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Lysine	MR Egger	14.1387958957129	12	0.291933005702033
met-a-330	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Nonadecanoate (19:0)	Inverse variance weighted	13.9683818704351	8	0.0825932625122724
met-a-330	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Nonadecanoate (19:0)	MR Egger	13.6739491380608	7	0.0572938294892375
met-a-332	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oleate (18:1n9)	Inverse variance weighted	20.5478977744041	13	0.0823655157352158
met-a-332	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oleate (18:1n9)	MR Egger	20.024316130354	12	0.0666273793080048
met-a-334	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Myristate (14:0)	Inverse variance weighted	22.1313378729009	17	0.179720724875591
met-a-334	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Myristate (14:0)	MR Egger	21.8679323103558	16	0.147507239738343
met-a-351	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Valine	Inverse variance weighted	1.70227459588006	4	0.790304399359312
met-a-351	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Valine	MR Egger	1.24876373785618	3	0.741334056224681
met-a-373	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-03094	Inverse variance weighted	9.86076131526265e-32	2	1
met-a-395	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Dihomo-linoleate (20:2n6)	Inverse variance weighted	0.0749248661989095	2	0.963230602629391
met-a-395	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Dihomo-linoleate (20:2n6)	MR Egger	1.23259516440783e-32	1	1
met-a-401	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Gamma-glutamylleucine	Inverse variance weighted	0.452850968559436	6	0.998365835022703
met-a-401	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Gamma-glutamylleucine	MR Egger	0.336531050281708	5	0.996899046846044
met-a-412	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-06246	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-420	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	2-hydroxybutyrate (AHB)	Inverse variance weighted	9.86076131526265e-32	2	1
met-a-423	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoylglycerol (1-monopalmitin)	Inverse variance weighted	0.923021994678496	3	0.819868816083735
met-a-423	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoylglycerol (1-monopalmitin)	MR Egger	0	2	1
met-a-428	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-08766	Inverse variance weighted	9.86076131526265e-32	2	1
met-a-469	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alanine	Inverse variance weighted	0.0285139575022701	3	0.998730323605759
met-a-469	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alanine	MR Egger	1.54074395550979e-33	2	1
met-a-477	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Myristoleate (14:1n5)	Inverse variance weighted	1.57772181044202e-30	2	1
met-a-482	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	10-undecenoate (11:1n1)	Inverse variance weighted	9.86076131526265e-32	2	1
met-a-497	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-linoleoylglycerophosphoethanolamine*	Inverse variance weighted	9.86076131526265e-32	2	1
met-a-559	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoleoylglycerophosphocholine*	Inverse variance weighted	1.57772181044202e-30	2	1
met-a-566	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-12038	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-576	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Palmitoleate (16:1n7)	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-623	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	5-dodecenoate (12:1n7)	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-654	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoylglycerophosphoethanolamine	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-705	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-myristoylglycerophosphocholine	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-706	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-oleoylglycerophosphoethanolamine	Inverse variance weighted	3.94430452610506e-31	2	1
met-a-707	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoylglycerophosphoethanolamine	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-840	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alanine	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-843	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Apolipoprotein B	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-844	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Ratio of bisallylic groups to double bonds	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-845	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Ratio of bisallylic groups to total fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-848	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Average number of methylene groups in a fatty acid chain	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-851	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Average number of double bonds in a fatty acid chain	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-852	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	22:6, docosahexaenoic acid	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-853	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Free cholesterol to esterified cholesterol ratio	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-855	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Omega-3 fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-856	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Omega-6 fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-857	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Omega-7, omega-9 and saturated fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-861	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glycerol	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-863	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glycoprotein acetyls	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-872	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in IDL	Inverse variance weighted	0.0407719526239517	3	0.997837006796697
met-c-872	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in IDL	MR Egger	1.23259516440783e-32	2	1
met-c-873	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Isoleucine	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-886	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total cholesterol in large VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-887	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Cholesterol esters in large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-888	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Free cholesterol in large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-889	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in large VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-890	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of large VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-891	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in large VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-892	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-893	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	18:2, linoleic acid (LA)	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-894	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Lactate	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-896	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Mean diameter for LDL particles	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-897	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Leucine	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-902	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of medium HDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-903	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in medium HDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-909	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total cholesterol in medium VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-910	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Cholesterol esters in medium VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-911	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Free cholesterol in medium VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-912	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in medium VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-913	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of medium VLDL particles	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-914	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in medium VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-915	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in medium VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-916	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Mono-unsaturated fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-917	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-918	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phosphatidylcholine and other cholines	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-920	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Pyruvate	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-921	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in small HDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-922	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of small HDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-923	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in small HDL	Inverse variance weighted	1.74996909174612	3	0.625882253279181
met-c-923	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in small HDL	MR Egger	5.74697495405151e-30	2	1
met-c-924	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total cholesterol in small LDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-925	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in small LDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-926	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of small LDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-928	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Free cholesterol in small VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-929	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in small VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-930	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of small VLDL particles	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-931	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in small VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-932	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in small VLDL	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-934	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Serum total triglycerides	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-936	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total fatty acids	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-937	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total phosphoglycerides	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-940	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Valine	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-941	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Mean diameter for VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-949	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in very large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-950	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of very large VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-951	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in very large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-952	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in very large VLDL	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-956	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in very small VLDL	Inverse variance weighted	0.878513013347055	3	0.830609771453668
met-c-956	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in very small VLDL	MR Egger	1.51069944837735e-30	2	1
met-c-957	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Total lipids in chylomicrons and largest VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-958	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Concentration of chylomicrons and largest VLDL particles	Inverse variance weighted	9.86076131526265e-32	2	1
met-c-959	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phospholipids in chylomicrons and largest VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
met-c-960	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Triglycerides in chylomicrons and largest VLDL particles	Inverse variance weighted	3.94430452610506e-31	2	1
